SCYNEXIS INC
Calidad de datos: 100%
SCYX
Nasdaq
Manufacturing
Chemicals
$1.00
▲
$0.01
(0.81%)
Cap. Mercado: 44.31 M
Precio
$0.99
Cap. Mercado
44.31 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—
Quick Summary
Puntos Clave
Revenue grew 11.85% annually over 5 years — strong growth
Negative free cash flow of -5.28 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 438.10%
Crecimiento
Revenue Growth (5Y)
11.85%
Above sector avg (1.82%)
Revenue (1Y)449.95%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-21.28%
Above sector avg (-53.53%)
ROIC-27.48%
Net Margin-41.79%
Op. Margin-78.03%
Seguridad
Debt / Equity
N/A
Current Ratio5.75
Interest Coverage-92.91
Valoración
PE (TTM)
-5.15
Below sector avg (-1.48)
P/B Ratio1.22
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1366 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1366 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.2 | -1.5 |
| P/B | 1.2 | 1.6 |
| ROE % | -21.3 | -53.5 |
| Net Margin % | -41.8 | -41.5 |
| Rev Growth 5Y % | 11.9 | 1.8 |
| D/E | — | 0.3 |
Precio Objetivo de Analistas
3 analistas
Buy
Actual
$1.00
Objetivo
$3.47
$3.00
$3.42
$4.00
Pronóstico
P/E Futuro
-3.03
EPS Futuro
-$0.33
Ingresos Est.
6.68 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
-$0.33
-$0.53 – -$0.20
|
6.68 M | 3 |
| FY2026 |
-$0.49
-$0.59 – -$0.34
|
1.15 M | 3 |
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| 2026 Q2 |
-$0.13
-$0.15 – -$0.10
|
80,330.0 | 3 |
| 2026 Q1 |
-$0.13
-$0.14 – -$0.10
|
77,000.0 | 3 |
Sorpresas de Ganancias
Últimos 4 trimestres
| Trimestre | EPS Est. | EPS Real | Sorpresa |
|---|---|---|---|
| Q42025 | $0.13 | $0.25 | +97.4% |
| Q32025 | -$0.20 | -$0.17 | +15.0% |
| Q22025 | -$0.19 | -$0.14 | +26.3% |
| Q12025 | -$0.19 | -$0.11 | +43.1% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 449.95% | Revenue Growth (3Y) | -61.66% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.85% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 20.60 M | Net Income (TTM) | -8.61 M |
| ROE | -21.28% | ROA | -15.41% |
| Gross Margin | N/A | Operating Margin | -78.03% |
| Net Margin | -41.79% | Free Cash Flow (TTM) | -5.28 M |
| ROIC | -27.48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 5.75 |
| Interest Coverage | -92.91 | Asset Turnover | 0.37 |
| Working Capital | 40.23 M | Tangible Book Value | 36.43 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -5.15 | Forward P/E | N/A |
| P/B Ratio | 1.22 | P/S Ratio | 2.15 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -11.92% | ||
| Market Cap | 44.31 M | Enterprise Value | 29.51 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.17 | Revenue / Share | 0.46 |
| FCF / Share | -0.12 | OCF / Share | -0.12 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 61.37% |
| SBC-Adj. FCF | -8.35 M | Growth Momentum | 438.10 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.60 M | 3.75 M | 140.14 M | 5.09 M | 13.16 M |
| Net Income | -8.61 M | -21.29 M | 67.04 M | -62.81 M | -32.87 M |
| EPS (Diluted) | -0.17 | -0.44 | 1.39 | -1.47 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -16.07 M | -37.12 M | 72.67 M | -85.76 M | -60.84 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 22.28 M | 26.41 M | 30.93 M | 27.26 M | 23.77 M |
| SG&A Expenses | 14.40 M | 14.46 M | 20.92 M | 62.96 M | 49.92 M |
| D&A | — | 0.0 | 580,000.0 | 606,000.0 | 379,000.0 |
| Interest Expense | 173,000.0 | 828,000.0 | 3.13 M | 5.20 M | 2.66 M |
| Income Tax | 0.0 | 151,000.0 | 138,000.0 | -4.70 M | -3.09 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 59.03 M | 90.64 M | 128.41 M | 87.81 M | 119.84 M |
| Total Liabilities | 9.65 M | 35.57 M | 55.45 M | 84.58 M | 78.58 M |
| Shareholders' Equity | 49.38 M | 55.08 M | 72.96 M | 3.23 M | 41.26 M |
| Total Debt | — | — | — | 34.39 M | 28.75 M |
| Cash & Equivalents | 21.26 M | 16.05 M | 34.05 M | 45.81 M | 104.48 M |
| Current Assets | 40.37 M | 72.18 M | 102.12 M | 79.06 M | 109.38 M |
| Current Liabilities | 5.73 M | 24.10 M | 16.30 M | 17.62 M | 13.62 M |
{"event":"ticker_viewed","properties":{"ticker":"SCYX","listing_kind":"stock","pathname":"/stocks/scyx","exchange":"Nasdaq","country":"US"}}
